Ostarine is one of the most well-studied and most popular SARMs on the market. At this time, GTx (who have been developing the SARM) have conducted over 8 clinical trials on MK-2866 on about 600 hundred subjects. Since the early 2000s, the discoveries made about Ostarine have led to it...